RecruitingNCT02998788

Risk Evaluation and Management in Heart Failure


Sponsor

Ruijin Hospital

Enrollment

1,000 participants

Start Date

Jun 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating the risks of heart failure getting worse and developing tools to better manage patients who are hospitalized with heart failure — including those with fluid buildup in the lungs, shock from a failing heart, or very high-output heart problems. **You may be eligible if...** - You are 18 years or older - You are admitted to the hospital with heart failure symptoms such as fluid in the lungs, swelling, or cardiogenic shock (heart not pumping enough blood) - You have had impaired heart function confirmed by an echocardiogram (ultrasound of the heart) - You are able to give informed consent **You may NOT be eligible if...** - You refuse to participate in the baseline assessment or follow-up visits - You have serious other illnesses that significantly reduce life expectancy - Your condition is too severe or unstable to safely participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02998788


Related Trials